← Back to all signals
RESEARCH PAPER ANALYSIS

Tympanoplsty with or without mastoidectmy is highly effective treatment of chronic otitis media in padiatric age group.

AI interpretation is pending for this paper.

Open original publication →
PMID42250460
JournalInternational journal of pediatric otorhinolaryngology
Publication Date2026-05-28
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: The study was conducted to assess the prognostic value of different variables on the outcome of a Type first tympanoplasty alone and combined with intact canal wall mastoidectomy in Chronic Otitis Media (CSOM) in pediatric patients. DESIGN: The Retrospective study. STUDY SELECTION: The Retrospective study was conducted from April 2017 to April 2023, in which200 pediatric patients were assessed in Department of Otorhinolaryngology and Head & Neck Surgery in territory rural health center. In which 140 patients were enrolled our study according to the selective criteria. All 140 patients presented with diminished hearing loss and ear symptoms. The complete Clinical examination, Otoscopic, tuning forks test, and radiological evaluation were done in all patients. Hearing assessments were done by manual pure-tone audiometry for all patients. Those patients who suffered from rhino sinusitis, adenoid hypertrophy, Furunculosis, Otomycosis, cholesteatoma ear, craniofacial dysmorphias and suspicious malignancy of external and middle ear were excluded from study. A Retrospective study of each patient medical record was undertaken, demographic, preoperative and postoperative information was recorded. Manual Pure Tone Audiometric data was recorded according to previously published guideline of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). Eustachian tube function assessment done by tympanometry of all patients after 12 weeks of surgery. All one forty patients had ear diseases and impaired hearing was identified. All patients were age between 06 yrs and 18 yrs. The patients were divided into two groups, one in which tympanoplasty type first (Group-1) was performed and other intact canal wall mastoidectomy with tympanoplasty type first (Group-2). All the surgeries were performed by post aural approach under general anesthesia. The autologous temporalis fascia was used as graft material in all surgeries and medial graft technique was performed in all cases. The resulting data were recorded for further comparison and analysis. For the purpose of this study, success was defined for each patient using the following three criteria: [5] INTERVENTION: None. RESULTS: All one forty patients with ear diseases and impaired hearing were selected according to the inclusion criteria. The patients were divided into two groups, one in which tympanoplasty type first (Group-1) was performed and other intact canal wall mastoidectomy with tympanoplasty type first (Group-2). All the patients were followed up for at least 6 months to 5years. Our study shows females, 82 (59%) were more common than males 58 (41%) patients. Ear diseases and hearing loss involved commonly in right ear (76) than the left ear (64). Chronic Suppurative Otitis Media (CSOM) with Tympanic Membrane perforation were found in 130 (93%) cases, Retraction pocket was 6 (4%) and 4 (3%) patients had atelectasis. Ninety-Two patients have age group between 15 years and 18 years of age. The Large central perforation found in 61 patients. The success rate of tympanic membrane healing was very high in the entire groups in our study. 100 percentages healing of T.M. was found in 06 years to 10 years of age groups. Our study shows 96.57% success rate of graft healing in intact canal wall mastoidectomy with type first tympanoplasty and 89.77% show in type first tympanoplasty in pediatric age group. Our study shows 91.30% improve of conductive hearing loss in intact canal wall mastoidectomy with type first tympanoplasty and 88.57% show in type first tympanoplasty in healed graft in pediatric age group. Five out of one forty patients were improving hearing from 50dB-80dB to 30 dB and 35 dB respectively. The overall success rate of the conductive hearing was about 90 percentages. We performed analysis of the predictive variables according to the success criteria of the healing with the normal hearing.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Prevalence and Associations for Use of Complementary and Alternative Medicine (CAM) Among Paediatric Cancer Patients in Norway: A Cross-Sectional Survey. Integrative cancer therapies 69.0 2 Portal cavernoma: epidemiological, clinical, etiological and outcome profiles - a 15-year retrospective study in a University Hospital in Rabat, Morocco. The Pan African medical journal 63.5 3 Artificial intelligence in Vietnamese healthcare: public awareness, demand, and willingness to pay. BMC health services research 60.2 4 Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge - A Case Report. Case reports in oncology 49.0 5 The unbalanced needs and perceived supply of supportive care in family caregivers of patients with multiple myeloma: a cross-sectional study. BMC palliative care 59.9 6 Development and Optimization of 111 In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection. bioRxiv : the preprint server for biology 77.4 7 High-Resolution Subtyping of Pediatric Low-Grade Glioma Using an Integrated Meta-Clustering Framework. bioRxiv : the preprint server for biology 67.5 8 Concordance of rapid whole genome and targeted long read sequencing of pediatric brain tumors with standard clinical testing. Research square 61.9 9 Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit. bioRxiv : the preprint server for biology 57.6 10 Clinical Presentation of, Treatment Approaches for, and the Impact of Social Determinants of Health on Pediatric Catatonia: A Structured Qualitative Synthesis and Targeted Literature Review. Cureus 66.04 11 Sequential Philadelphia-Positive Pre-B Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia With Distinct BCR::ABL1 Fusion Transcripts. Cancer reports (Hoboken, N.J.) 67.1 12 Intracranial germ cell tumours presenting with AVP deficiency and evolving panhypopituitarism: diagnostic pitfalls in early imaging and biopsy. Endocrinology, diabetes & metabolism case reports 64.0 13 A Subset of FOXO1-Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and "Burkitt-Like" Morphology Is Associated With High Amplification of MYCL: A Report From the Children's Oncology Group. Genes, chromosomes & cancer 57.5 14 Pediatric lynch-associated melanoma arising in ovarian teratoma: a case report. Gynecologic oncology reports 55.1 15 Case Report: Case series: growth hormone replacement for severe growth hormone deficiency during BRAF inhibitor therapy in pediatric low-grade glioma: long-term follow-up. Frontiers in endocrinology 70.3 16 Prognostic value of lymph node ratio in children with wilms tumor: a systematic review and meta-analysis. Frontiers in oncology 79.6 17 Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss. Frontiers in immunology 69.1 18 Combined aromatherapy and music or sound for emotional distress: a systematic review of controlled studies published between 2019 and 2026. Frontiers in psychology 84.84 19 Longitudinal follow-up of autoimmune neutropenia in adults-a single-cohort experience. Frontiers in immunology 69.8 20 A spectrum of tumorigenesis in an IDH1-mosaic patient with Ollier disease, acute myeloid leukaemia, and parathyroid adenoma. Frontiers in genetics 57.0 21 From armed-conflict to care: clinical outcomes, diagnostic challenges, and psychosocial burden in children evaluated for suspected cancer displaced from Gaza and treated at a regional center of excellence. Frontiers in oncology 68.2 22 Clinical and radiological features of posterior reversible encephalopathy syndrome in children: a retrospective study. Frontiers in pediatrics 69.3 23 Case Report: Cytomegalovirus-associated granulomatous lung disease in an immunocompetent preterm infant. Frontiers in immunology 47.5 24 Atypical echocardiographic phenotype of end-stage hypertrophic cardiomyopathy: a case series. Frontiers in cardiovascular medicine 57.0 25 Utilizing BRAF/MEK Inhibitors to Reduce Morbidity in a Pediatric Patient With Ameloblastoma: A Case Report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 55.26 26 EWSR1-FLI1 expression combined with monoallelic EWSR1 depletion is associated with mitotic spindle damage and nocodazole sensitivity. Biology open 53.3 27 Real-World Outcomes of Total Body Irradiation versus Chemotherapy-Based Conditioning in Pediatric Acute Lymphoblastic Leukemia. Clinical epidemiology 74.84 28 Structure and Function of Archaeal SRP54 Protein Mutants Associated with Human Severe Congenital Neutropenia. ACS omega 55.0 29 Minibeam Radiotherapy in Pediatric Cancer: First Clinical Use in a Treatment-Refractory Sarcoma. Pediatric blood & cancer 58.3 30 Refractory Idiopathic Infantile Pyoderma Gangrenosum Successfully Treated With Infliximab: A Case Report. Case reports in pediatrics 61.72 31 Prospective evaluation of serum methotrexate pharmacokinetics following intrathecal methotrexate in acute lymphoblastic leukaemia. British journal of haematology 62.8 32 Gradient-driven microfluidic framework for the screening of ratiometric drug combinations towards precision oncology in paediatric leukaemia. Nature biomedical engineering 64.16
PATIENT-FRIENDLY SUMMARY

Tympanoplsty with or without mastoidectmy is highly effective treatment of chronic otitis media in padiatric age group.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic